Featured Editorial

  1. FDA Staffing Constraints And Operational Risk In Clinical Supply 2/11/2026

    FDA staffing shortages and supply pressures are reshaping clinical trials, requiring closer coordination across regulatory, manufacturing, and operations.

  2. Tariffs Threaten Clinical Trial Supply Chains: Preparing For Volatility 2/10/2026

    Tariffs and FDA staffing gaps are quietly reshaping clinical trial supply chains. From comparators to customs delays, these forces are creating real risk for timelines, budgets, and patients.

  3. The Key Role Of Clinical Supply Teams In Patient Centricity Efforts 2/9/2026

    Clinical supply decisions shape patient access, safety, and trial success. From logistics to procurement, patient-centric supply can accelerate therapies or quietly delay them.

  4. How Clinical Supply Teams Pull Better Demand Signals 2/6/2026

    Clinical supply teams reduce risk by using site-level enrollment data, screen failure rates, and amendment impacts to guide material commitments and plan for uncertainty.

  5. Why Clinical Supply Risk Starts With Demand Signals 2/5/2026

    Clinical supply risk often begins long before manufacturing or distribution. Flawed demand signals and enrollment forecasts can quietly create shortages, delays, and costly material waste.

  6. Clinical Supply Planning In A More Volatile And Regionalized World 2/4/2026

    Global shifts are rewriting the rules of clinical supply. Rising costs, regional regulations, and material scarcity mean planners must rethink strategies or risk costly disruptions.

  7. Navigating Brazil's Medical Device Clinical Trial Import Process 1/27/2026

    When medtech sponsors plan clinical trials in Brazil, many overlook a critical bottleneck that can delay trial launches by months: the process of importing clinical trial materials.

  8. Where Clinical Supply Chain Meets Humanity: Why It's Never "Just A Box" 1/27/2026

    Clinical supply chain decisions move more than inventory. They influence dignity, safety, and patient outcomes every day.

  9. Managing Supply Chain Risk In Scale-Up And Multisite Trials 1/23/2026

    Scaling trials across sites can lock in supply risk early. Learn how biologic variability, long lead times, and multisite complexity threaten trials and how to spot warning signs fast.

  10. Global Clinical Supply — Confronting Persistent Challenges With Strategic Action 1/21/2026

    From regulatory fragmentation to cold chain risks, discover how strategic action, data visibility, and resilient design keep clinical trials on track.